Deep Track Capital
$6.8B 13F equity value
80 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Deep Track Capital covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| GH | GUARDANT HEALTH INC | 3,393,312 | $509M | 7.5% |
| IMVT | IMMUNOVANT INC | 9,341,151 | $360M | 5.3% |
| GPCR | STRUCTURE THERAPEUTICS INC | 4,740,072 | $254M | 3.7% |
| PCVX | VAXCYTE INC | 4,300,000 | $250M | 3.7% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 825,000 | $248M | 3.7% |
| MANE | VERADERMICS INC | 2,000,000 | $246M | 3.6% |
| TARS | TARSUS PHARMACEUTICALS INC | 3,666,768 | $231M | 3.4% |
| NUVL | NUVALENT INC | 1,783,322 | $220M | 3.2% |
| ALKS | ALKERMES PLC | 4,000,000 | $210M | 3.1% |
| OCUL | OCULAR THERAPEUTIX INC | 19,686,282 | $193M | 2.8% |
Track Deep Track Capital's 13F portfolio: $6.8B in reported holdings, 80 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}